. . . . . . . . . . "SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study"@en . . . . "A Phase 3, Open-label, Multicenter, 12-month Extension Safety and Tolerability Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder With Residual Symptoms or Inadequate Response Following Treatment With an Antidepressant"@en . . "2012-02-01T00:00:00Z"^^ . . "1570"^^ . . . . . . "clinical trial"@en . . . . . . . . . . . . "klinisch onderzoek"@nl . . . . . . . . "65"^^ . . . "ensayu cl\u00EDnicu"@ast . . "SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study"@en . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . . . . . . . "2014-02-01T00:00:00Z"^^ . . . . . . . . . . . . . . "SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study"@en . . . . . . . . . . "NCT01436175" . . . . "18"^^ . . . .